Wednesday, February 27, 2013 Tuesday, February 26, 2013- Jazz Pharmaceuticals Public Limited Management Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Feb 26)
- Jazz Pharmaceuticals Public Crushes Earnings Estimatesat Motley Fool (Tue, Feb 26)
- Jazz Pharmaceuticals Earnings: Here’s Why Investors are Buying Shares Nowat Wall St. Cheat Sheet (Tue, Feb 26)
- JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andEDGAR Online (Tue, Feb 26)
- Jazz Pharmaceuticals Earnings Call scheduled for 4:30 pm ET todayCCBN (Tue, Feb 26)
- Jazz Pharmaceuticals plc and Concert Pharmaceuticals Announce Worldwide Licensing Agreement to Develop and Commercialize Deuterium-Modified Sodium OxybateBusiness Wire (Tue, Feb 26)
- Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial ResultsPR Newswire (Tue, Feb 26)
- Vivus Falls On Fat Q4 Loss, Thin Sales Of Obesity Drug Qsymiaat Investor's Business Daily (Tue, Feb 26)
- Q4 2012 Jazz Pharmaceuticals Earnings Release - After Market CloseCCBN (Tue, Feb 26)
Monday, February 25, 2013 Thursday, February 21, 2013 Monday, February 11, 2013 Monday, February 4, 2013 Tuesday, January 22, 2013 Friday, January 18, 2013 Thursday, January 17, 2013 Tuesday, January 15, 2013 Monday, January 14, 2013Add JAZZ News to My Yahoo!  | |
|